malacidin A

Term ID

CHEBI:140173

Synonyms

N-[(4S,7R,10S,13S,16S,22R,25S,29R,30aS)-10-(4-aminobutyl)-22-(1-carboxyethyl)-13-[carboxy(hydroxy)methyl]-16-(carboxymethyl)-7,25-diisopropyl-3,29-dimethyl-1,5,8,11,14,17,20,23,26-nonaoxotriacontahydropyrrolo[2,1-c][1,4,7,10,13,16,19,22,25]nonaazacyclooct

Definition

A homodetic cyclic peptide containing a 28-membered ring and consisting of 3-methyl-N-[(2E,4Z)-8-methylnona-2,4-dienoyl]-L-alpha-aspartyl, (2S)-2,3-diaminobutanoyl, D-valyl, L-lysyl, 3-hydroxy-L-alpha-aspartyl, L-alpha-aspartyl, glycyl, 3-methyl-D-alpha-aspartyl, L-valyl, and (4R)-methyl-L-proline joined in sequence and cyclised by condensation of the beta-amino group of the 2,3-diaminobutanoyl residue with the carboxy group of the 4-methylproline residue.

References

Ontology

ChEBI ( EBI )

Relationships

is a type of: homodetic cyclic peptide lipopeptide

homodetic cyclic peptide lipopeptide Show first 5 Terms
has_role: antibacterial agent bacterial metabolite calcium-dependent antibiotics

antibacterial agent bacterial metabolite calcium-dependent antibiotics Show first 5 Terms

Phenotype

Phenotype resulting from malacidin A

Phenotype where environments contain malacidin A

Phenotype modified by environments containing malacidin A

Human Disease Model